ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,520Medicare Part D Prescriptions Filled, Including Refills

Rank: 181 out of 680

$663K Total Retail Price of All Prescriptions

Rank: 177 out of 680

407 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 407 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

14% of this provider’s 407 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 9,336 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
WARFARIN SODIUM 380 325 1 20
LEVOTHYROXINE SODIUM 369 311 2 2
SIMVASTATIN 331 286 3 3
AMLODIPINE BESYLATE 330 250 4 1
OMEPRAZOLE 317 275 5 7
NAMENDA 256 245 6 35
GABAPENTIN 224 192 7 15
FUROSEMIDE 223 205 8 6
LISINOPRIL 213 135 9 5
POTASSIUM CHLORIDE 213 184 9 14
METOPROLOL TARTRATE 206 172 11 12
DONEPEZIL HCL 190 182 12 27
CARVEDILOL 188 134 13 23
QUETIAPINE FUMARATE 160 151 14 64
HYDROCODONE-ACETAMINOPHEN 159 134 S3 15 4
NEXIUM 157 129 16 16
TRAMADOL HCL 154 118 17 18
BUMETANIDE 151 124 18 102
MIRTAZAPINE 144 134 19 78
ATORVASTATIN CALCIUM 140 117 20 11
TAMSULOSIN HCL 122 111 21 34
METFORMIN HCL 118 101 22 8
KLOR-CON M10 110 96 23 127
LANTUS 108 85 24 49
ENALAPRIL MALEATE 102 81 25 65
KLOR-CON M20 95 89 26 61
DOXYCYCLINE HYCLATE 89 63 27 95
BYSTOLIC 86 59 28 79
ZOLPIDEM TARTRATE 86 70 28 17
CIPROFLOXACIN HCL 86 74 28 57
PRAVASTATIN SODIUM 85 75 31 10
JANUVIA 85 60 31 60
SERTRALINE HCL 83 68 33 28
METOPROLOL SUCCINATE 83 67 33 13
SANTYL 81 69 35 170
LOVASTATIN 79 61 36 44
CITALOPRAM HBR 77 71 37 22
CEPHALEXIN 76 48 38 149
DILTIAZEM HCL 76 69 38 291
CRESTOR 72 46 40 25
SEROQUEL 71 69 41 123
CLOPIDOGREL 70 42 42 26
MEGESTROL ACETATE 70 54 R 42 88
ADVAIR DISKUS 70 49 42 53
RISPERIDONE 70 66 42 80
OLANZAPINE 68 55 46 116
CYMBALTA 67 67 47 46
ALENDRONATE SODIUM 67 67 47 32
ESCITALOPRAM OXALATE 66 58 49 45
TERAZOSIN HCL 65 45 50 180
CLOTRIMAZOLE-BETAMETHASONE 63 52 51 138
FLUOXETINE HCL 61 44 52 74
POLYETHYLENE GLYCOL 3350 60 52 53 62
SPIRONOLACTONE 58 45 54 82
INSULIN SYRINGE 57 44 55 86
PAROXETINE HCL 57 43 55 76
DIVALPROEX SODIUM 54 50 57 110
ATENOLOL 52 40 58 19
TRIAMTERENE-HCTZ 52 43 58 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.